仙乐健康（300791）(300791.SZ)发布公告，为深化公司全球化战略布局，利用国际资本市场优势，打 造多元化资本运作平台，进一步提高公司资本实力和综合竞争力，以加快海外业务发展，完善境内外双 循环格局，巩固行业地位，公司拟发行境外上市外资股(H股)股票并申请在香港联交所主板挂牌上市。 ...

Group 1 - The core viewpoint of the article is that Xianle Health (300791.SZ) plans to issue overseas listed foreign shares (H-shares) and apply for listing on the main board of the Hong Kong Stock Exchange to enhance its global strategy and capital strength [1] Group 2 - The company aims to leverage the advantages of international capital markets to create a diversified capital operation platform [1] - The initiative is intended to accelerate the development of overseas business and improve the domestic and international dual circulation pattern [1] - This move is expected to strengthen the company's competitive position within the industry [1]

仙乐健康公告，公司于2026年1月8日召开第四届董事会第十七次会议，审议通过了拟发行H股股票并在 香港联交所主板上市的相关议案。此举旨在深化全球化战略布局，利用国际资本市场优势，提高公司资 本实力和综合竞争力，加快海外业务发展，完善境内外双循环格局，巩固行业地位。目前，公司正与相 关中介机构就发行并上市事宜进行商讨，具体细节尚未最终确定。 ...